Research Article
BibTex RIS Cite

Aromatic Phosphinous Amides: A Promising New Generation of Antibiotics for Multidrug-Resistant Bacterial Infections

Year 2024, Volume: 28 Issue: 5, 1800 - 1811, 28.06.2025

Abstract

There is a focus on using aromatic phosphinous amide as an antibacterial agent against serious multidrug resistant bacterial infections. N–(4–acetylphenyl)–P,P–diphenyl-phosphinous amide and its corresponding thioxo- phosphinous amide and selenoxo-phosphinous amide were synthesized and designated Ph1, Ph2, and Ph3, respectively. They were structurally identified by single crystal X-ray diffraction, multinuclear NMR spectroscopy, and elemental analysis. Because their antibacterial activities have never been examined, this study aimed to assess their antibacterial activities against both Gram-positive and Gram-negative bacteria as well as readily available standard bacterial strains. Two bacterial isolates were isolated from urine specimens collected from patients with urinary tract infections and designated CS1, and CS2. Phenotypic, biochemical, and molecular approaches were used to identify them. The antibiotic susceptibility/resistance pattern of these isolates was examined by the installed VITEK 2 system. Isolate CS1 is an aerobic Gram-positive, straight rod-shaped, spore forming, occurring singly or in a short chain, whereas isolate CS2 is an aerobic Gram-negative, coccobacilli-shaped, non-spore forming, occurring in pairs or in chains. Both isolates are positive for catalase and oxidase test. According to an examination of the 16S rRNA gene sequence, the isolates CS1 and CS2 have 98% of their similarities with Bacillus and Acinetobacter species, respectively. Isolates CS1 and CS2 are multidrug resistance species. Based on the results of the minimum inhibitory concentration, the standard bacterial strains and isolates CS1 and CS2 showed a wide range in the antibacterial capabilities of the studied phosphinous amides. In comparison to Ph2 and Ph3, Ph1 has the strongest antibacterial activity against all of the tested bacterial species. In conclusion, CS1 and CS2 isolates were identified as novel, multi-drug resistant members of the Bacillus and Acinetobacter genera, respectively. The Ph1 molecule represents a promising new generation of antibiotics with notable antibacterial efficacy against multidrug-resistant Gram-positive and Gram-negative microorganisms.

References

  • [1] Ayukekbong JA, Ntemgwa M, Atabe AN. The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrobial Resist Infect Control. 2017; 6 (1): 47. https://doi.org/ 10.1186/s13756- 017-0208-x
  • [2] Irshaid FI, Jacob HJ, and Alhawamdeh SI. The slaughtering and dressing procedures of livestock inside the butcher shops generate high levels of bacterial contamination. Journal of Basic and Applied Sciences. 2018; 14:165-173 165. https://doi.org/10.6000/1927-5129.2018.14.25
  • [3] Pokharel S, Raut S, Adhikari B. Tackling antimicrobial resistance in low-income and middle-income countries. BMJ Glob Health. 2019; 4 (6): e002104. https://doi.org/10.1136/bmjgh-2019-002104
  • [4] Geneva: World Health Organization. Antibacterial Agents in Clinical Development: An Analysis of the Antibacterial Clinical Development Pipeline. Licence: CC BY-NC-SA 3.0 IGO, 2019. Available online: https://apps.who.int/iris/handle/10665/330420 (accessed on 23 September 2022).
  • [5] Jacob JH, Irshaid FI, Al-Soud Y. Antibacterial activity of some selected 1,2,4-Triazole derivatives against standard, environmental, and medical bacterial strains. Advanced Studies in Biology. 2013; 5(6): 291-30. https://doi.org/10.12988/asb.2013.3418
  • [6] Jacob HJ, Irshaid FI, Al-Soud YA, Al-Balushi AM, Al-Arqan H R. Synthesis, characterization and evaluation of antibacterial activity of six novel 1,2,4-Triazole derivatives against standard and medical bacteria. Advanced Studies in Biology. 2013; 5 (6): 303 – 318. https://doi.org/10.12988/asb.2013.3419
  • [7] Villemin D, Moreau B, Bar N. MCR under Microwave Irradiation: Synthesis in water of new 2-amino-bis(2-phosphonoacetic) acids. Organics. 2021; 2: 98-106. https://doi.org/ 10.3390/org2020009 .
  • [8] Al-Masri HT, Moussa Z. Synthesis and X- ray structures of thioxo- and selenoxo- phosphino species derived from monooxidation of new N-(4-acetylphenyl)-P,P- diphenylphosphinous amide ligand. Inorganic and Nano-Metal Chemistry. 2017; 48 (1): 67-73. https://doi.org/10.1080/24701556.2017. 1357633
  • [9] Huang Q, Zhu L, Yi D, Zhao X, Wei W. Silver-mediated aminophosphinoylation of propargyl alcohols with aromatic amines and H-phosphine oxides leading to α-aminophosphine oxides. Chinese Chem. Lett. 2020; 31: 373–376, https://doi.org/10.1016/j.cclet. 2019.07.049
  • [10] Kafarski P. Phosphonopeptides containing free phosphonic groups: Recent advances. RSC Adv. 2020; 10: 25898–25910. https://doi.org/10.1039/D0RA04655H
  • [11] Naydenova ED, Todorov PT, Mateeva PI, Zamfirova RN, Pavlov ND, Todorov SB. Synthesis and biological activity of novel small peptides with amino phosphonates moiety as NOP receptor ligands. Amino Acids. 2010; 39: 1537-1543. https://doi.org/10.1007/s00726-010-0624-1
  • [12] Irshaid FI, Jacob JH. Isolation and molecular identification of new benzene degrading Lysinibacillus strains from gasoline contaminated soil. Research Journal of Environmental and Earth Sciences. 2016; 8 (4): 34-43. http://dx.doi.org/10.19026/rjees. 8.3064.
  • [13] CLSI. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-fifth Informational Supplement. CLSI document M100-S25. Wayne, PA: Clinical and Laboratory Standards Institute. 2015.
  • [14] Drancourt M, Bollet C, Carlioz A, Martelin R, Gayral JP, Raoul D. 16S ribosomal sequence analysis of a large collection of environmental and clinical unidentifiable bacterial isolates. J. Clin. Microbiol. 2000; 38: 3623–3630. https://doi.org/10.1128/JCM.38.10.3623-3630.2000
  • [15] Celandroni F, Vecchione A, Cara A, Mazzantini D, Lupetti A, Ghelardi E. Identification of Bacillus species: Implication on the quality of probiotic formulations. PLoS ONE. 2019; 14(5): e0217021. https://doi.org/10.1371/journal.pone.0217021.
  • [16] Bottone EJ. Bacillus cereus, a volatile human pathogen. Clin Microbiol Rev. 2010; 23:382-398. https://doi: 10.1128/CMR.00073-09
  • [17] Carroll LM, Wiedmann M, Kovac J. Proposal of a taxonomic nomenclature for the Bacillus cereus group which reconciles genomic definitions of bacterial species with clinical and industrial phenotypes. M. Bio. 2019; 10 (3): e00853-19. https://doi.org/10.1128/mBio .00034-20.
  • [18] Baldwin VM. You Can’t B. cereus – A Review of Bacillus cereus strains that cause anthrax-like disease. Front. Microbiol. 2020; 11:1731. https://doi.org/10.3389/fmicb.2020.01731.
  • [19] Jiménez G, Urdiain M, Cifuentes A, López-López A, Blanch AR, Tamames J, et al. Description of Bacillus toyonensis sp. nov., a novel species of the Bacillus cereus group, and pairwise genome comparisons of the species of the group by means of ANI calculations. Syst. Appl. Microbiol. 2013; 36: 383–391. https://doi.org/10.1016/j.syapm.2013.04.008
  • [20] Jung J, Park W. Acinetobacter species as model microorganisms in environmental microbiology: Current state and perspectives. The Journal of Applied Microbiology and Biotechnology. 2015; 99: 2533-2548. https://doi.org/10.1007/s00253-015-6439-y
  • [21] Raut S, Rijal KR, Khatiwada S, Karna S, Khanal R, Adhikari J, Adhikari B. Trend and Characteristics of Acinetobacter baumannii Infections in Patients Attending Universal College of Medical Sciences, Bhairahawa, Western Nepal: A Longitudinal Study of 2018. Infection and drug resistance. 2020; 13:1631–1641. https://doi.org/10.2147/IDR. S257851.
  • [22] Kurcik-Trajkovska B. Acinetobacter spp. – a serious enemy threatening hospitals worldwide. Macedonian Journal of Medical Sciences. 2009; 2: 157-162. https://doi.org/10.3889/MJMS. 1857-5773.2009.0043
  • [23] Banerjee T, Mishra A, Das A, Sharma S, Barman H, Yadav G. High prevalence and endemicity of multidrug resistant Acinetobacter spp. In intensive care unit of a tertiary care hospital, Varanasi, India. J Pathog. 2018; 9129083. https://doi.org/10.1155/2018/ 9129083 .
  • [24] Citron DM, Shawish R., Tarabees R. Prevalence and antimicrobial resistance of Bacillus cereus isolated from beef products in Egypt. Open Veterinary Journal. 2017; 7(4):337–341.https://doi. org/10.4314/ovj.v7i4.9.
  • [25] Fiedler G, Schneider C, Igbinosa EO, et al. Antibiotics resistance and toxin profiles of Bacillus cereus-group isolates from fresh vegetables from German retail markets. BMC Microbiol. 2019; 19: 250. https://doi.org/10.1186/s12866-019-1632-2
  • [26] Gupta N, Gandham N, Jadhav S, Mishra RN. Isolation and identification of Acinetobacter species with special reference to antibiotic resistance. J Nat Sc Biol Med. 2015; 6:159-62. https://doi.org/10.4103/0976-9668.149116
  • [27] Jung J, Park W. Acinetobacter species as model microorganisms in environmental microbiology: Current state and perspectives. The Journal of Applied Microbiology and Biotechnology. 2015; 99: 2533-2548. https://doi.org/10.1007/s00253-015-6439-y
  • [28] Raut S., Rijal K. R., Khatiwada S., Karna S., Khanal R., Adhikari J., Adhikari B. Trend and Characteristics of Acinetobacter baumannii infections in patients attending universal college of medical sciences, Bhairahawa, Western Nepal: A Longitudinal Study of 2018. Infection and drug resistance. 2020; 13:1631–1641. https://doi.org/10.2147/IDR. S257851.
  • [29] Horsman GP, Zechel DL. Phosphonate biochemistry. Chem. Rev. 2017; 117: 5704–5783. doi: 10.1021/acs.chemrev.6b00536. https://doi.org/10.1021/acs.chemrev.6b00536
  • [30] Carramiñana V, Ochoa de Retana AM, Palacios F, de los Santos JM. Synthesis of α-Aminophosphonic acid derivatives through the addition of O- and s-nucleophiles to 2H-azirines and their antiproliferative effect on A549 human lung adenocarcinoma cells. Molecules. 2020; 25(15):3332. https://doi.org/10.3390/molecules25153332.
  • [31] Drag M, Wieczerzak E, Pawełczak M, Berlicki Ł, Grzonka Z, Kafarski P. Toward very potent, non-covalent organophosphonate inhibitors of cathepsin C and related enzymes by 2-amino-1-hydroxy-alkanephosphonates dipeptides. Biochimie. 2013; 95(8):1640-1649. https://doi.org/10.1016/j.biochi.2013.05.006.
  • [32] Wessjohann LA, Schneider A, Abbas M, Brandt W. Selenium in chemistry and biochemistry in comparison to sulfur. Biological Chemistry. 2007; 388(10): 997–1006. https://doi.org/ 10.1515/BC.2007.138.
  • [33] Rapp M, Margas-Musielak K, Kaczmarek P, Witkowska A, Cytlak T, Siodła T, Koroniak H. Highly diastereoselective construction of carbon–heteroatom quaternary stereogenic centers in the synthesis of analogs of bioactive compounds: From monofluorinated epoxyalkylphosphonates to α-fluoro-, β-, or γ -amino alcohol derivatives of alkylphosphonates. Front. Chem. 2021, 9:613633. https://doi.org/10.3389/fchem. 2021.613 633.
  • [34] Sabnis A, Hagart KL, Klöckner A, Becce M, Evans LE, Furniss RCD, Mavridou DA, Murphy R, Stevens MM, Davies JC, Larrouy-Maumus GJ, Clarke TB, Edwards AM. Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane. Elife. 2021, 10:e65836. https://doi.org/10.7554/eLife.65836.
There are 34 citations in total.

Details

Primary Language English
Subjects Pharmacology and Pharmaceutical Sciences (Other)
Journal Section Articles
Authors

Fawzi Irshaid Irshaid 0000-0003-0364-3135

Samia Ramadan Eshawakh 0009-0007-8642-4902

Abdelrahim Hunaiti 0000-0003-4737-6999

Harbi Tomah Al-masri 0000-0001-6928-1152

Publication Date June 28, 2025
Published in Issue Year 2024 Volume: 28 Issue: 5

Cite

APA Irshaid, F. I., Eshawakh, S. R., Hunaiti, A., Al-masri, H. T. (2025). Aromatic Phosphinous Amides: A Promising New Generation of Antibiotics for Multidrug-Resistant Bacterial Infections. Journal of Research in Pharmacy, 28(5), 1800-1811.
AMA Irshaid FI, Eshawakh SR, Hunaiti A, Al-masri HT. Aromatic Phosphinous Amides: A Promising New Generation of Antibiotics for Multidrug-Resistant Bacterial Infections. J. Res. Pharm. July 2025;28(5):1800-1811.
Chicago Irshaid, Fawzi Irshaid, Samia Ramadan Eshawakh, Abdelrahim Hunaiti, and Harbi Tomah Al-masri. “Aromatic Phosphinous Amides: A Promising New Generation of Antibiotics for Multidrug-Resistant Bacterial Infections”. Journal of Research in Pharmacy 28, no. 5 (July 2025): 1800-1811.
EndNote Irshaid FI, Eshawakh SR, Hunaiti A, Al-masri HT (July 1, 2025) Aromatic Phosphinous Amides: A Promising New Generation of Antibiotics for Multidrug-Resistant Bacterial Infections. Journal of Research in Pharmacy 28 5 1800–1811.
IEEE F. I. Irshaid, S. R. Eshawakh, A. Hunaiti, and H. T. Al-masri, “Aromatic Phosphinous Amides: A Promising New Generation of Antibiotics for Multidrug-Resistant Bacterial Infections”, J. Res. Pharm., vol. 28, no. 5, pp. 1800–1811, 2025.
ISNAD Irshaid, Fawzi Irshaid et al. “Aromatic Phosphinous Amides: A Promising New Generation of Antibiotics for Multidrug-Resistant Bacterial Infections”. Journal of Research in Pharmacy 28/5 (July 2025), 1800-1811.
JAMA Irshaid FI, Eshawakh SR, Hunaiti A, Al-masri HT. Aromatic Phosphinous Amides: A Promising New Generation of Antibiotics for Multidrug-Resistant Bacterial Infections. J. Res. Pharm. 2025;28:1800–1811.
MLA Irshaid, Fawzi Irshaid et al. “Aromatic Phosphinous Amides: A Promising New Generation of Antibiotics for Multidrug-Resistant Bacterial Infections”. Journal of Research in Pharmacy, vol. 28, no. 5, 2025, pp. 1800-11.
Vancouver Irshaid FI, Eshawakh SR, Hunaiti A, Al-masri HT. Aromatic Phosphinous Amides: A Promising New Generation of Antibiotics for Multidrug-Resistant Bacterial Infections. J. Res. Pharm. 2025;28(5):1800-11.